Tag: Icovamenib

Biomea’s Icovamenib Drug Shows Potential for Diabetes Patients

Biomea’s icovamenib shows lasting blood sugar reduction in type 2 diabetes, offering new hope for patients unresponsive to GLP-1 treatments.